Latest Australian Market News

EVE Health Group has secured regulatory approval enabling prescription access for its lead products Libbo and Dyspro in Australia, setting the stage for a commercial rollout before the end of 2025.

RBR Group stands uniquely positioned as the only ASX-listed company directly linked to Mozambique’s LNG megaprojects, gearing up for a sector revival and broader African growth.

BKI Investment Company Limited reported a modest rise in revenue and operating profit for FY2025, alongside a 1% increase in dividends, supported by robust returns from key portfolio holdings.

Centrepoint Alliance has reported a robust FY25 with EBITDA rising 16% and net profit before tax jumping 30%, driven by strong adviser growth and strategic platform launches.

Little Green Pharma reported a robust June 2025 quarter with record cash receipts and expanding European footprint, highlighted by a new production capacity in Denmark and the launch of its CherryCo brand in Germany.

betr Entertainment Limited has launched an all-scrip takeover bid for PointsBet Holdings Limited, offering 3.81 betr shares for every PointsBet share, valuing PointsBet at $1.22 per share and promising significant cost synergies.

Kinterra Capital has lodged a formal review application against the Takeovers Panel’s earlier ruling involving New World Resources, signaling potential shifts in the ongoing corporate governance saga.

Lendlease has expanded its Australian development pipeline with a landmark $2.5 billion luxury residential project at 175 Liverpool Street, Sydney, signaling strong confidence in the high-end market and its strategic growth plans.

Finbar Group has signed a conditional contract to sell a key Rivervale site for $13.68 million, paving the way for a large-scale build-to-rent development backed by community housing initiatives.

Orthocell Limited has posted a record quarterly revenue of A$2.73 million, driven by strong Australian sales of its nerve repair product Remplir™, with US market expansion poised to accelerate in FY26.

IAG has revised its FY25 financial guidance upward, citing a $200 million reduction in expected natural perils costs, including significant claims from recent NSW floods. This update lifts profit and margin forecasts amid steady premium growth.

The Federal Court of Australia has approved Dollarama’s acquisition of The Reject Shop, setting the stage for a significant shift in the Australian discount retail landscape. Shareholders are poised to receive a special dividend and a cash payout as the scheme becomes effective.